Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ads Free, Unlimited access)​
NO CREDIT CARD REQUIRED

Doximity Inc (DOCS)DOCS

Upturn stock ratingUpturn stock rating
Doximity Inc
$40.06
Delayed price
PASS
upturn advisory
  • BUY Advisory
  • Profitable SELL
  • Loss-Inducing SELL
  • Profit
  • Loss ​
  • PASS (Skip invest)*​ ​
Upturn Stock price based out of last closeUpturn Stock price based out of last close Stock price based out of last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK
Time period over

Upturn Advisory Summary

09/18/2024: DOCS (1-star) is currently NOT-A-BUY. Pass it for now.

Analysis of Past Upturns

Type: Stock
Upturn Star Rating​ Upturn stock ratingUpturn stock rating
Today’s Advisory: PASS
Profit: -43.96%
Upturn Advisory Performance Upturn Advisory Performance1
Avg. Invested days: 27
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Stock Returns Performance Upturn Returns Performance 1
Last Close 09/18/2024
Type: Stock
Today’s Advisory: PASS
Profit: -43.96%
Avg. Invested days: 27
Upturn Star Rating​ Upturn stock ratingUpturn stock rating
Stock Returns Performance Upturn Returns Performance 1
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 09/18/2024
Upturn Advisory Performance Upturn Advisory Performance1

Key Highlights

Company Size Mid-Cap Stock
Market Capitalization 7.32B USD
Price to earnings Ratio 50.2
1Y Target Price 34.29
Dividends yield (FY) -
Basic EPS (TTM) 0.8
Volume (30-day avg) 2138022
Beta 1.27
52 Weeks Range 19.71 - 40.99
Updated Date 09/18/2024
Company Size Mid-Cap Stock
Market Capitalization 7.32B USD
Price to earnings Ratio 50.2
1Y Target Price 34.29
Dividends yield (FY) -
Basic EPS (TTM) 0.8
Volume (30-day avg) 2138022
Beta 1.27
52 Weeks Range 19.71 - 40.99
Updated Date 09/18/2024

Earnings Date

Report Date -
When -
Estimate -
Actual -
Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin 32.53%
Operating Margin (TTM) 36.51%

Management Effectiveness

Return on Assets (TTM) 10.61%
Return on Equity (TTM) 16.86%

Revenue by Products

Revenue by Products - Current and Previous Year

Valuation

Trailing PE 50.2
Forward PE 38.61
Enterprise Value 6719672695
Price to Sales(TTM) 14.83
Enterprise Value to Revenue 13.61
Enterprise Value to EBITDA 33.87
Shares Outstanding 125165000
Shares Floating 120530862
Percent Insiders 3.3
Percent Institutions 93.67
Trailing PE 50.2
Forward PE 38.61
Enterprise Value 6719672695
Price to Sales(TTM) 14.83
Enterprise Value to Revenue 13.61
Enterprise Value to EBITDA 33.87
Shares Outstanding 125165000
Shares Floating 120530862
Percent Insiders 3.3
Percent Institutions 93.67

Analyst Ratings

Rating 3.33
Target Price 26.3
Buy 2
Strong Buy 4
Hold 10
Sell -
Strong Sell 2
Rating 3.33
Target Price 26.3
Buy 2
Strong Buy 4
Hold 10
Sell -
Strong Sell 2

AI Summarization

Comprehensive Overview of Doximity Inc.

Company Profile:

History and Background: Doximity Inc. (DOCS) is a leading digital platform for healthcare professionals in the United States. Founded in 2010, the company initially focused on building a professional social networking platform for doctors, similar to LinkedIn. Over time, Doximity has diversified its offerings, expanding into telemedicine, e-prescribing, and other healthcare-related services.

Core Business Areas:

  • Social Networking: Doximity's flagship platform connects over 2.2 million verified U.S. healthcare professionals, enabling secure communication, collaboration, and knowledge sharing.
  • Telehealth: Doximity Dialer offers HIPAA-compliant video conferencing and secure messaging for virtual consultations.
  • E-Prescribing: Doximity's e-prescribing solution streamlines the prescription process for healthcare providers.
  • Other Services: Doximity also provides career development resources, educational tools, and a marketplace for medical supplies.

Leadership and Corporate Structure: Doximity is led by CEO and Founder, Dr. Jeff Tangney. The executive team comprises experienced industry veterans with expertise in healthcare, technology, and business development. The company operates under a single-class stock structure, with Dr. Tangney holding a controlling interest.

Top Products and Market Share:

Top Products:

  • Doximity Network: The largest online professional network for U.S. healthcare professionals.
  • Doximity Dialer: A HIPAA-compliant telehealth platform.
  • Doximity ePrescribe: An electronic prescribing solution.

Market Share:

  • Social Networking: Doximity holds a dominant market share in the U.S. online professional network for healthcare professionals, with over 80% penetration among physicians.
  • Telehealth: Doximity Dialer is gaining traction, but faces competition from established players like Teladoc and Amwell.
  • E-Prescribing: Doximity's e-prescribing solution has a growing market share, but competes with larger players like Surescripts and Allscripts.

Product Performance and Competitive Comparison:

  • Doximity's Network enjoys high user engagement and positive feedback. Dialer's user base is growing, and ePrescribe is gaining traction through integrations with Electronic Health Records (EHRs).
  • Compared to competitors, Doximity's focus on the U.S. healthcare market and its integrated platform provide a competitive advantage. However, larger competitors have established market share and wider adoption in specific segments.

Total Addressable Market:

The global digital health market is estimated to reach $356.8 billion by 2027, with the U.S. market accounting for a significant portion. The market for online professional networks, telehealth solutions, and e-prescribing solutions within this sector represents Doximity's total addressable market.

Financial Performance:

Recent Financial Statements: Doximity's revenue has grown significantly in recent years, driven by strong user growth and expansion into new services. Profitability is also improving, with the company achieving its first profitable quarter in Q2 2023.

Year-over-Year Comparison: Revenue and earnings per share (EPS) have shown consistent year-over-year growth. The company has a strong balance sheet with significant cash reserves.

Cash Flow and Balance Sheet: Doximity generates strong operating cash flow and maintains a healthy balance sheet with low debt levels. This provides the company with the financial flexibility to invest in growth initiatives and pursue acquisitions.

Dividends and Shareholder Returns:

Dividend History: Doximity is currently not paying dividends, as the company prioritizes reinvesting its profits into growth.

Shareholder Returns: Doximity's stock has performed exceptionally well since its IPO in 2021, delivering strong returns for investors.

Growth Trajectory:

Historical Growth: Doximity has experienced rapid user and revenue growth over the past few years. The company has expanded its product offerings and established partnerships with major healthcare organizations.

Future Growth Projections: Analysts expect Doximity's growth to continue, driven by increasing adoption of its platform by healthcare professionals and expansion into new markets and service offerings.

Recent Product Launches and Strategic Initiatives: Doximity continues to launch new features and services, such as Dialer's appointment scheduling capabilities and integrations with EHRs. The company is also pursuing strategic partnerships to expand its reach and deepen its engagement with healthcare professionals.

Market Dynamics:

Industry Trends: The digital health market is undergoing significant growth, driven by factors like the increasing adoption of telehealth, the shift towards value-based care, and the rising prevalence of chronic diseases.

Doximity's Positioning: Doximity is well-positioned to benefit from these trends with its focus on building a comprehensive platform for healthcare professionals. The company's strong brand recognition, user engagement, and strategic partnerships give it a competitive edge.

Adaptability to Market Changes: Doximity has demonstrated its ability to adapt to changing market dynamics, as evidenced by its expansion into new service areas and its focus on data-driven innovation.

Competitors:

Key Competitors:

  • Teladoc (TDOC)
  • Amwell (AMWL)
  • Surescripts (SURI)
  • Allscripts (MDRX)

Market Share and Comparison: Doximity leads in the online professional network space for healthcare professionals. In telehealth and e-prescribing, it faces competition from established players with larger market share. However, Doximity's integrated platform and focus on the U.S. market offer differentiation.

Potential Challenges and Opportunities:

Key Challenges:

  • Maintaining rapid user growth and engagement.
  • Expanding into new markets and services while maintaining profitability.
  • Competing with larger established players in the telehealth and e-prescribing markets.

Potential Opportunities:

  • Expanding internationally.
  • Developing new features and services that cater to the evolving needs of healthcare professionals.
  • Leveraging data and analytics to personalize user experiences and improve platform engagement.

Recent Acquisitions (last 3 years):

Doximity has not made any acquisitions in the last 3 years.

AI-Based Fundamental Rating:

Rating: 8.5 out of 10

Justification: Doximity possesses strong fundamentals, supported by its:

  • Leading market position in the U.S. healthcare professional network space.
  • High user engagement and growth potential.
  • Strong financial performance and healthy balance sheet.
  • Diversified product offerings and strategic partnerships.

While competition remains a challenge, Doximity's focus on innovation and its unique positioning within the healthcare market provide a strong foundation for future growth.

Sources and Disclaimers:

Sources:

  • Doximity Investor Relations website
  • SEC filings
  • Market research reports

Disclaimer: This information is intended for general knowledge and informational purposes only and does not constitute financial advice. It is essential to conduct your own research and due diligence before making any investment decisions.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.​

About Doximity Inc

Exchange NYSE Headquaters San Francisco, CA, United States
IPO Launch date 2021-06-24 Co-Founder, CEO & Chairperson Mr. Jeffrey A. Tangney
Sector Healthcare Website https://www.doximity.com
Industry Health Information Services Full time employees 827
Headquaters San Francisco, CA, United States
Co-Founder, CEO & Chairperson Mr. Jeffrey A. Tangney
Website https://www.doximity.com
Website https://www.doximity.com
Full time employees 827

Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with digital tools built for medicine, that enables its members to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits. It primarily serves physicians, nurse practitioners, physician assistants, medical students, pharmaceutical manufacturers, and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​